Table 4.1 PRIMARY CARE HETEROPHORIA EXAMINATION AND TREATMENT | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
These questionnaires, illustrated in Figures 4.1 and 4.2, are standardized instruments that have been shown to be valid and reliable for measuring the type and frequency of symptoms for patients with convergence insufficiency and intermittent exotropia, respectively.3,4,5,6,7 Either can be used in clinical practice to efficiently determine whether a patient has symptoms related to binocular vision, accommodative, or eye movement disorders.
1. Use a 20/30 line (or an acuity line two lines above threshold).
2. With the left eye occluded, add plus (0.25 diopters [D] at a time) to the objective findings until the right eye is barely able to read the 20/30 threshold line. If too much plus is used, the next step will be difficult, so you may want to back off slightly (add -0.25 D, at most).
3. Perform Jackson cross-cylinder (JCC) testing (adding plus in the earlier step allows the patient to make more accurate JCC responses).
4. Repeat for the left eye, with the right eye occluded.
5. Add prism (3 Δ up before the right eye; 3 Δ down before the left eye) and +0.75 D to each eye.
6. Perform a dissociated balance by adding plus to the clearer target until both eyes are reported to be equally blurred.
7. Remove the dissociating prism and slowly add minus until the patient can just read 20/20. Do not arbitrarily add some amount of minus.
8. Place the vectographic slide in the projector with analyzers in the phoropter. Place “I” target with letters on each side in the patient’s view and ask if both sides are equally clear. If not, add +0.25 D to the clearer side. This is a binocular balance but not a true binocular refraction (in which the JCC would be performed under these conditions as well).
9. Perform stereopsis testing.
10. Return to the standard slide and check visual acuity. If the patient cannot see 20/15, check whether -0.25 more OU improves the acuity. It is virtually never necessary to add more than -0.50 OU total. Do not arbitrarily add some amount of minus.
1. Purpose Vergence facility testing is designed to assess the dynamics of the fusional vergence system and the ability to respond over a period of time.
2. Important issues
(a) Strength of prism to use and target to use Gall et al8 performed a systematic study of vergence facility and found that the magnitude of choice is 3 Δ base-in/12 Δ base-out. This combination of prism yielded the highest significance for separating symptomatic from nonsymptomatic subjects as well as producing repeatable results (R = 0.85) when used for near vergence facility testing. In another study, Gall et al9 compared the use of three different vertically oriented targets for vergence facility testing and found that vergence facility is nearly independent of the target and that a simple vertical column of 20/30 letters is an appropriate target.
1. Purpose The purpose of the near point of convergence is to assess convergence amplitude. A remote near point of convergence was found to be the most frequently used criterion by optometrists for diagnosing convergence insufficiency.12
2. Important issues
(a) Target to be used and number of times to perform the test We recommend repeating the near point of convergence twice—first using an accommodative target and then using a transilluminator or penlight with red/green glasses.
1. Purpose In contrast to cover testing, which is done under conditions in which one eye is covered and fusion is prevented, fixation disparity testing is designed to evaluate binocular vision under associated conditions.
2. Important issues
(a) Fixation disparity testing is performed under binocular conditions The main deficiency of the typical phoria measurement is that the evaluation occurs under dissociated conditions. Although some clinicians suggest the routine use of fixation disparity testing, we have found that in the majority of cases, phoria/vergence testing is sufficient to reach a tentative diagnosis and management plan. In situations in which the diagnosis is unclear or a vertical or base-out prism prescription is being considered, fixation disparity testing is an important addition to the examination procedure.
(b) Determination of prism correction Fixation disparity is currently considered the method of choice for determining the amount of prism to prescribe for vertical heterophoria.